title: Clinical predictors of treatment reduction in hypertensive patients.
abstract: OBJECTIVE
  To demonstrate that some hypertensive patients under good blood pressure (BP) control can reduce medications, and to identify predictors of successful reduction.
  
  
  METHODS
  Observational study with 11-month follow-up.
  
  
  METHODS
  Outpatient hypertension clinic at the Seattle Veterans Administration Hospital.
  
  
  METHODS
  59 males (51% of those eligible) with diastolic BP less than 95 mm Hg for greater than or equal to 6 months; 57 patients (97%) completed the study.
  
  
  METHODS
  Gradual reduction of medications unless diastolic BP rose above 95 mm Hg.
  
  
  RESULTS
  Intensity of treatment with BP medications was assessed using a scale of their comparative "vigors." 35 patients (59%) reduced medications successfully. By the end of the study, systolic BP had risen by 8.2 +/- 12.3 mm Hg (mean +/- SD) in successful patients, while diastolic BP did not change significantly. Two predictors of treatment reduction were statistically significant in both univariate and multivariate analyses: successful patients had been treated more intensively (2.7 +/- 1.7 vs. 1.3 +/- 0.5 "vigor units," p = 0.0001), and they had been enrolled in the clinic longer (5.5 +/- 3.0 vs. 3.1 +/- 2.3 years, p = 0.003). Lower systolic BP, higher urinary sodium excretion, lower compliance, and younger age were significant predictors of treatment reduction on univariate analysis only. Age less than or equal to 65 years had the highest sensitivity (86%) for treatment reduction, while treatment with two or more "vigor units" had the highest specificity (79%) and likelihood ratio (3.3).
  
  
  CONCLUSIONS
  Treatment reduction is feasible in many well-controlled hypertensives, though systolic BP rises. Patients with high intensity and long duration of treatment are most likely to reduce medications successfully.
authors.affiliation: Department of Medicine, University of Colorado Health Sciences Center, Denver 80262.
authors.forename: J F
authors.initials: JF
authors.lastname: Steiner
authors.forename: S D
authors.initials: SD
authors.lastname: Fihn
authors.forename: T D
authors.initials: TD
authors.lastname: Koepsell
authors.forename: B
authors.initials: B
authors.lastname: Blair
authors.forename: K
authors.initials: K
authors.lastname: Kelleher
authors.forename: D
authors.initials: D
authors.lastname: D'Alessandro
authors.forename: T S
authors.initials: TS
authors.lastname: Inui
mesh_terms: D000959:Antihypertensive Agents / Q000008:administration & dosage* / Q000627:therapeutic use; D001294:Attitude to Health; D001794:Blood Pressure / Q000502:physiology; D002985:Clinical Protocols; D004334:Drug Administration Schedule; D006801:Humans; D006973:Hypertension / Q000517:prevention & control* / Q000523:psychology; D008297:Male; D008875:Middle Aged; D015999:Multivariate Analysis; D010349:Patient Compliance; D013997:Time Factors
chemical_list: D000959:Antihypertensive Agents